Early infantile epileptic encephalopathy associated with the disrupted gene encoding Slit-Robo Rho GTPase activating

Hirotomo Saitsu1, Hitoshi Osaka, Shirou Sugiyama

  • 1Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Kanazawa-ku, Yokohama, Japan. hsaitsu@yokohama-cu.ac.jp

Insights

A de novo balanced translocation disrupted the SRGAP2 gene, causing early infantile epileptic encephalopathy and West syndrome in a patient. This finding links SRGAP2 gene abnormalities to severe early-onset epilepsy.

Area of Science:

  • Genetics
  • Neuroscience
  • Developmental Biology

Background:

  • Early infantile epileptic encephalopathy (EIEE) and West syndrome are severe neurodevelopmental disorders with complex genetic underpinnings.
  • Balanced translocations can disrupt gene function, leading to congenital abnormalities and developmental disorders.

Observation:

  • A female infant presented with early infantile epileptic encephalopathy, severe psychomotor disability, and clonic convulsions shortly after birth.
  • Electroencephalogram (EEG) findings evolved from an atypical suppression-burst pattern to hypsarrhythmia, indicative of West syndrome.
  • A de novo balanced translocation, t(1;9)(q32;q13), was identified in the patient.

Findings:

  • Nucleotide-level mapping revealed translocation breakpoints disrupting the SRGAP2 gene at 1q32.1 and a heterochromatic region at 9q13.
  • The Slit-Robo Rho GTPase activating protein 2 (SRGAP2) gene is crucial for neuronal development, regulating migration, neurite outgrowth, and branching.
  • This study is the first to report an SRGAP2 gene abnormality associated with early infantile epileptic encephalopathy.

Implications:

  • The disruption of SRGAP2 due to the translocation is strongly implicated as the cause of the patient's severe neurological phenotype.
  • This finding highlights the critical role of SRGAP2 in human brain development and its potential involvement in other neurodevelopmental disorders.
  • Understanding the functional consequences of SRGAP2 disruption may offer new avenues for diagnosing and potentially treating early-onset epileptic encephalopathies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...